Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Indivior Pharmaceuticals, Inc. (INDV)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS)
All
(5)
DE
(4)
US
(1)
NASDAQ (NGS)
Primary
XFRA
XMUN
XDUS
XETRA
$
32.
45
-1.17
-3.4801%
$
4.19B
Market Cap
-
P/E Ratio
-
Div Yield
4.29M
Volume
1.35
Eps
$
33.62
Previous Close
Investors:
ABB
JD
MA
LN
+56
Watching
Watch
Add Transaction
Day Range
32.31
33.84
Year Range
23.72
42.81
Want to track
INDV
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
News
Historical Data
Investors
Indivior Pharmaceuticals, Inc. (INDV) Statistics
Valuation metrics
Market Cap
4.19B
Enterprise value
4.34B
Trailing P/E (ttm)
11.43
Forward P/E
9.65
PEG ratio
0.06
Price/Sales (ttm)
3.04
Price/Book (mrq)
-19.56
Enterprise Value/Revenue
3.26
Enterprise Value/EBITDA
9.92
Overview
Shares outstanding
122M
Float
103.78M
Shares short
12.82M
% Held by insiders
0.01%
% Held by institutions
1.05%
Average volume (10 days)
3.29M
Average volume (90 days)
2.31M
Price summary
52-Week low
23.72
52-Week high
42.81
Beta
1.2
50-Day moving average
35.19
200-Day moving average
36.82
Dividends and splits
Forward annual dividend rate
-
Forward annual dividend yield
-
Trailing annual dividend rate
-
Trailing annual dividend yield
-
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
29 Jul 2016
Ex-Dividend Date
16 Jun 2016
Last split factor
1:5
Last split Date
10 Oct 2022
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.27%
Operating margin
0.39%
Operational effectiveness
Return on assets
0.29%
Return on equity
-2.16%
Income Statement
Revenue (ttm)
1.29B
Revenue per share (ttm)
10.63
Quarterly revenue growth (yoy)
0.19%
Gross profit (ttm)
1.1B
EBITDA
374M
Net income to common (ttm)
252M
Diluted EPS (ttm)
2.83
Quarterly earnings growth (yoy)
0.89%
Balance Sheet
Total cash (mrq)
175M
Total cash per share (mrq)
1.77
Total debt (mrq)
509M
Total Debt/Equity (mrq)
-2.45
Current ratio (mrq)
0.84%
Book value per share (mrq)
-1.66
Cash Flow
Cash flow statement
-111M
Levered free cash flow (LFCF)
44.25M